Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 46 | 2024 | 3148 | 5.680 |
Why?
|
Spirometry | 18 | 2024 | 904 | 2.310 |
Why?
|
Forced Expiratory Volume | 16 | 2024 | 1789 | 2.020 |
Why?
|
Vital Capacity | 12 | 2024 | 953 | 1.690 |
Why?
|
Actigraphy | 4 | 2023 | 496 | 1.060 |
Why?
|
Pulmonary Emphysema | 5 | 2020 | 688 | 1.040 |
Why?
|
DNA Methylation | 6 | 2021 | 4259 | 1.030 |
Why?
|
Lung | 17 | 2024 | 9918 | 1.020 |
Why?
|
Exercise Tolerance | 6 | 2022 | 789 | 1.000 |
Why?
|
Veterans | 8 | 2024 | 2528 | 0.860 |
Why?
|
Total Lung Capacity | 3 | 2020 | 149 | 0.820 |
Why?
|
Smoking | 16 | 2023 | 8983 | 0.800 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2022 | 186 | 0.780 |
Why?
|
Exercise | 6 | 2023 | 5688 | 0.770 |
Why?
|
Thorax | 1 | 2023 | 543 | 0.720 |
Why?
|
Epigenesis, Genetic | 4 | 2021 | 3654 | 0.540 |
Why?
|
Absorptiometry, Photon | 1 | 2022 | 1736 | 0.520 |
Why?
|
Klinefelter Syndrome | 1 | 2015 | 47 | 0.500 |
Why?
|
Telomere | 1 | 2019 | 905 | 0.450 |
Why?
|
Blood Cells | 1 | 2015 | 299 | 0.440 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17445 | 0.440 |
Why?
|
Respiratory Function Tests | 5 | 2020 | 1667 | 0.440 |
Why?
|
Mouth Mucosa | 1 | 2015 | 428 | 0.420 |
Why?
|
Walking | 1 | 2020 | 1163 | 0.420 |
Why?
|
Adiposity | 1 | 2022 | 1825 | 0.400 |
Why?
|
Lung Diseases | 1 | 2021 | 1902 | 0.390 |
Why?
|
Dyspnea | 5 | 2024 | 1308 | 0.380 |
Why?
|
Genome-Wide Association Study | 10 | 2024 | 12217 | 0.380 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 865 | 0.360 |
Why?
|
Bronchitis, Chronic | 3 | 2024 | 82 | 0.360 |
Why?
|
Aged | 31 | 2023 | 164383 | 0.310 |
Why?
|
Middle Aged | 38 | 2023 | 214618 | 0.310 |
Why?
|
Williams Syndrome | 1 | 2010 | 190 | 0.300 |
Why?
|
Genome, Human | 3 | 2015 | 4358 | 0.280 |
Why?
|
CpG Islands | 4 | 2015 | 1199 | 0.280 |
Why?
|
Self Report | 1 | 2018 | 3589 | 0.280 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3659 | 0.270 |
Why?
|
Male | 39 | 2023 | 351420 | 0.250 |
Why?
|
Humans | 60 | 2024 | 746630 | 0.250 |
Why?
|
Female | 40 | 2023 | 382450 | 0.240 |
Why?
|
Carrier Proteins | 1 | 2017 | 4928 | 0.230 |
Why?
|
Aged, 80 and over | 12 | 2021 | 57586 | 0.220 |
Why?
|
Glucocorticoids | 1 | 2012 | 2119 | 0.220 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 2 | 2021 | 105 | 0.210 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 25184 | 0.210 |
Why?
|
Aging | 1 | 2021 | 8486 | 0.210 |
Why?
|
Sickle Cell Trait | 1 | 2022 | 87 | 0.200 |
Why?
|
Genomics | 1 | 2017 | 5695 | 0.190 |
Why?
|
Japan | 2 | 2022 | 1267 | 0.180 |
Why?
|
Smoking Cessation | 1 | 2012 | 2070 | 0.180 |
Why?
|
Bronchodilator Agents | 2 | 2021 | 507 | 0.170 |
Why?
|
Mucins | 1 | 2023 | 567 | 0.170 |
Why?
|
Disease Progression | 6 | 2021 | 13317 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2017 | 15386 | 0.160 |
Why?
|
Phenotype | 7 | 2023 | 16261 | 0.160 |
Why?
|
Quality of Life | 7 | 2023 | 12977 | 0.160 |
Why?
|
Body Composition | 2 | 2022 | 2384 | 0.160 |
Why?
|
Metabolomics | 2 | 2017 | 1571 | 0.150 |
Why?
|
Electric Impedance | 1 | 2022 | 732 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 484 | 0.140 |
Why?
|
Boston | 2 | 2022 | 9213 | 0.140 |
Why?
|
Mannose-Binding Lectin | 1 | 2018 | 146 | 0.140 |
Why?
|
Internet | 2 | 2020 | 3039 | 0.140 |
Why?
|
Body Mass Index | 2 | 2011 | 12657 | 0.140 |
Why?
|
Risk | 2 | 2020 | 9522 | 0.140 |
Why?
|
Self Efficacy | 1 | 2020 | 609 | 0.130 |
Why?
|
Cohort Studies | 8 | 2021 | 40534 | 0.130 |
Why?
|
Metabolism, Inborn Errors | 1 | 2018 | 281 | 0.130 |
Why?
|
Proteins | 1 | 2010 | 6007 | 0.130 |
Why?
|
Genotype | 5 | 2022 | 12788 | 0.130 |
Why?
|
Occupational Exposure | 2 | 2024 | 1800 | 0.120 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 23 | 0.120 |
Why?
|
Risk Factors | 13 | 2023 | 72447 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2019 | 21693 | 0.110 |
Why?
|
Respiratory System | 1 | 2016 | 554 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.110 |
Why?
|
Goals | 1 | 2018 | 696 | 0.110 |
Why?
|
Pulmonary Artery | 1 | 2021 | 1920 | 0.110 |
Why?
|
Ankyrins | 1 | 2012 | 121 | 0.100 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2012 | 41 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 166 | 0.100 |
Why?
|
Receptors, Thrombin | 1 | 2012 | 130 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1504 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15010 | 0.090 |
Why?
|
Checklist | 1 | 2018 | 807 | 0.090 |
Why?
|
Respiration | 1 | 2017 | 1644 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14124 | 0.090 |
Why?
|
Receptors, Peptide | 1 | 2012 | 276 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.090 |
Why?
|
Exercise Test | 1 | 2018 | 2081 | 0.090 |
Why?
|
Heterozygote | 1 | 2017 | 2767 | 0.090 |
Why?
|
United States | 6 | 2022 | 70437 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1847 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2020 | 38771 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20143 | 0.090 |
Why?
|
Norway | 1 | 2010 | 492 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 308 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2381 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2009 | 166 | 0.080 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 111 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 2012 | 495 | 0.080 |
Why?
|
Elastin | 1 | 2010 | 301 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 688 | 0.080 |
Why?
|
Prevalence | 2 | 2023 | 15312 | 0.080 |
Why?
|
Administration, Inhalation | 1 | 2021 | 1140 | 0.080 |
Why?
|
Motivation | 1 | 2017 | 1966 | 0.070 |
Why?
|
Social Support | 1 | 2017 | 2118 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2556 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2671 | 0.070 |
Why?
|
Adult | 11 | 2024 | 215192 | 0.070 |
Why?
|
Antigens, CD | 1 | 2016 | 3903 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4982 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7945 | 0.070 |
Why?
|
Osteoporosis | 1 | 2015 | 1581 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 11966 | 0.060 |
Why?
|
Chromosome Deletion | 1 | 2010 | 1391 | 0.060 |
Why?
|
Poland | 2 | 2017 | 194 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4399 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1215 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4562 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2009 | 2366 | 0.060 |
Why?
|
Asthma | 3 | 2017 | 6139 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19819 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5255 | 0.060 |
Why?
|
Gases | 1 | 2024 | 198 | 0.050 |
Why?
|
DNA | 1 | 2016 | 7208 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2021 | 78313 | 0.050 |
Why?
|
Depression | 2 | 2023 | 7826 | 0.050 |
Why?
|
Smoke | 1 | 2024 | 231 | 0.050 |
Why?
|
Bone Density | 1 | 2015 | 3511 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 144 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1867 | 0.050 |
Why?
|
Family | 1 | 2012 | 3157 | 0.050 |
Why?
|
Mucus | 1 | 2023 | 341 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10284 | 0.050 |
Why?
|
Dust | 1 | 2024 | 479 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13810 | 0.050 |
Why?
|
Sputum | 1 | 2023 | 489 | 0.050 |
Why?
|
Logistic Models | 2 | 2017 | 13170 | 0.050 |
Why?
|
Genetic Variation | 2 | 2021 | 6454 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6463 | 0.050 |
Why?
|
Veterans Health | 1 | 2022 | 203 | 0.050 |
Why?
|
Body Weight | 1 | 2010 | 4606 | 0.040 |
Why?
|
Infant | 1 | 2021 | 35456 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29079 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3333 | 0.040 |
Why?
|
Thymidine Phosphorylase | 1 | 1998 | 14 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2017 | 17869 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39622 | 0.040 |
Why?
|
HT29 Cells | 1 | 1998 | 191 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2022 | 866 | 0.040 |
Why?
|
Mice | 2 | 2017 | 80251 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10633 | 0.030 |
Why?
|
Animals | 3 | 2017 | 166558 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15555 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1511 | 0.030 |
Why?
|
Sarcoglycans | 1 | 2015 | 55 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15319 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 523 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7786 | 0.030 |
Why?
|
Breath Tests | 1 | 2016 | 291 | 0.030 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 229 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 57 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 53253 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 352 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2015 | 144 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1553 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2273 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1491 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4276 | 0.030 |
Why?
|
North America | 1 | 2015 | 1264 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2012 | 287 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 276 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3429 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 807 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5831 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 903 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2722 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2671 | 0.020 |
Why?
|
Cough | 1 | 2013 | 584 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2024 | 4315 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 63732 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3355 | 0.020 |
Why?
|
Morbidity | 1 | 2013 | 1744 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1876 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3086 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 20820 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1963 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 6990 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4617 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4868 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7815 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6837 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3033 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2679 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9599 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8384 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10096 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12021 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 57163 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10333 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10372 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 86278 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1998 | 191 | 0.010 |
Why?
|
Dactinomycin | 1 | 1998 | 312 | 0.010 |
Why?
|
Interferon-alpha | 1 | 1998 | 902 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1178 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1753 | 0.010 |
Why?
|
Kinetics | 1 | 1998 | 6361 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6517 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12456 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17689 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12767 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1998 | 8356 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1998 | 13586 | 0.000 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_